Karyopharm shareholders approve increase in authorized shares to 111M at special meeting

Karyopharm Therapeutics Inc.

Authorized common stock raised from 53,333,333 to 106,000,000; total capital shares from 58,333,333 to 111,000,000.
Vote: 9,436,123 for, 3,213,329 against, 25,465 abstain; adjournment proposal also approved but not needed.
Certificate of amendment filed with Delaware Secretary of State on February 18, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.